BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 31087035)

  • 1. Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.
    Dittmer U; Sutter K; Kassiotis G; Zelinskyy G; Bánki Z; Stoiber H; Santiago ML; Hasenkrug KJ
    FEMS Microbiol Rev; 2019 Sep; 43(5):435-456. PubMed ID: 31087035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection.
    Li SX; Barrett BS; Harper MS; Heilman KJ; Halemano K; Steele AK; Guo K; Silverman RH; Santiago ML
    Virology; 2013 Aug; 443(1):134-42. PubMed ID: 23725696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
    Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection.
    Schwerdtfeger M; Dickow J; Schmitz Y; Francois S; Karakoese Z; Malyshkina A; Knuschke T; Dittmer U; Sutter K
    Front Immunol; 2021; 12():809774. PubMed ID: 35126368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of NK cells in viral immunity during different phases of acute Friend retrovirus infection.
    Littwitz E; Francois S; Dittmer U; Gibbert K
    Retrovirology; 2013 Nov; 10():127. PubMed ID: 24182203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose of Retroviral Infection Determines Induction of Antiviral NK Cell Responses.
    Littwitz-Salomon E; Schimmer S; Dittmer U
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28904191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into Sensing of Murine Retroviruses.
    Moran EA; Ross SR
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative selection by an endogenous retrovirus promotes a higher-avidity CD4+ T cell response to retroviral infection.
    Young GR; Ploquin MJ; Eksmond U; Wadwa M; Stoye JP; Kassiotis G
    PLoS Pathog; 2012; 8(5):e1002709. PubMed ID: 22589728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.
    Nair S; Bayer W; Ploquin MJ; Kassiotis G; Hasenkrug KJ; Dittmer U
    Retrovirology; 2011 Sep; 8():76. PubMed ID: 21943070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Expression of a Viral RdRP Protects against Retrovirus Infection and Disease.
    Miller CM; Barrett BS; Chen J; Morrison JH; Radomile C; Santiago ML; Poeschla EM
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral immunology: lessons from a mouse model.
    Myers L; Hasenkrug KJ
    Immunol Res; 2009; 43(1-3):160-6. PubMed ID: 18830572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative impact of IFN-γ on early host immune responses to retroviral infection.
    Duley AK; Ploquin MJ; Eksmond U; Ammann CG; Messer RJ; Myers L; Hasenkrug KJ; Kassiotis G
    J Immunol; 2012 Sep; 189(5):2521-9. PubMed ID: 22821964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immunity in the Friend retrovirus infection model.
    Halemano K; Harper MS; Guo K; Li SX; Heilman KJ; Barrett BS; Santiago ML
    Immunol Res; 2013 Mar; 55(1-3):249-60. PubMed ID: 22961660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune control and prevention of chronic Friend retrovirus infection.
    Hasenkrug KJ; Dittmer U
    Front Biosci; 2007 Jan; 12():1544-51. PubMed ID: 17127401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3.
    Gibbert K; Francois S; Sigmund AM; Harper MS; Barrett BS; Kirchning CJ; Lu M; Santiago ML; Dittmer U
    Retrovirology; 2014 Dec; 11():126. PubMed ID: 25539593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B lymphocyte activation by coinfection prevents immune control of friend virus infection.
    Marques R; Antunes I; Eksmond U; Stoye J; Hasenkrug K; Kassiotis G
    J Immunol; 2008 Sep; 181(5):3432-40. PubMed ID: 18714015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fv1, the mouse retrovirus resistance gene.
    Stoye JP
    Rev Sci Tech; 1998 Apr; 17(1):269-77. PubMed ID: 9638816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.
    Knuschke T; Rotan O; Bayer W; Sokolova V; Hansen W; Sparwasser T; Dittmer U; Epple M; Buer J; Westendorf AM
    Retrovirology; 2016 Apr; 13():24. PubMed ID: 27076190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease.
    Gibbert K; Dietze KK; Zelinskyy G; Lang KS; Barchet W; Kirschning CJ; Dittmer U
    J Immunol; 2010 Nov; 185(10):6179-89. PubMed ID: 20943997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.